Related Experiment Video
Updated: Jun 18, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Persistent pneumonia: Underlying cause and outcome
Manish Kumar1, Niranjan Biswal, V Bhuvaneswari
1Dept of Pediatrics, JIPMER, Pondicherry, India.
Indian Journal of Pediatrics
|November 27, 2009
Summary
Persistent pneumonia in children is often caused by ongoing infections, aspiration, and weakened immune systems. Identifying these underlying causes is crucial for effective treatment and improved child health outcomes.
Area of Science:
- Pediatrics
- Infectious Diseases
- Pulmonology
Background:
- Persistent pneumonia presents a significant clinical challenge in pediatric care.
- Identifying the etiology of prolonged pneumonia is essential for targeted management.
Purpose of the Study:
- To determine the underlying causes and contributing factors of persistent pneumonia in pediatric patients.
- To investigate the diverse etiological spectrum of persistent pneumonia.
Main Methods:
- A comprehensive investigation of 41 pediatric cases with persistent pneumonia.
- Utilized biochemical, microbiological, histopathological, immunological, and radiological assessments.
Main Results:
- Identified pulmonary tuberculosis (8 cases) and Gram-negative bacterial infections (12 cases) as common infectious causes.
- Aspiration due to gastroesophageal reflux or oil instillation (12 cases) and HIV-related immunodeficiency (3 cases) were also significant factors.
- Congenital lung malformations (2 cases), cardiac disorders (2 cases), and foreign body aspiration (1 case) were less frequent causes.
Conclusions:
- Persistent infection emerged as the most frequent underlying cause of persistent pneumonia.
- Aspiration and acquired immunodeficiency were identified as the next most common etiological categories.
- The study highlights the multifactorial nature of persistent pneumonia in children, necessitating a broad diagnostic approach.
Related Concept Videos
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
01:30Pneumonia I: Introduction
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:29Pneumonia II: Pathophysiology
The pathophysiology of pneumonia involves the following steps: